An audit of treated epilepsy in Glasgow  by Muir, T.M. et al.
Seizure 1996; 5:41-46 
An audit of treated epilepsy in Glasgow 
T.M. MUIR, A. BRADLEY, S.F. WOOD, G.D. MURRAY & M.J. BRODIE on behalf of the West of 
Scotland Epilepsy Research Group 
Correspondence to: Professor Martin J. Brodie, Epilepsy Research Unit, Department of Medicine and Therapeutics, 
Western Infirmary, Glasgow G l l  6NT 
An audit of patients receiving antiepileptic drug therapy for epilepsy was carried out in 25 general practices in 
Glasgow. Patients were identified from computerized records of repeat prescriptions for antiepileptic drugs. 
Overall, 1052 (0.72%) of 145,609 screened patients had treated epilepsy. Only 5% were children, while 19% were 
over 65 years. Twenty-nine per cent were diagnosed by a neurologist, and in 24% no record was available of who 
had made the diagnosis. Fifty per cent had tonic-clonic seizures only. Partial seizures occurred in 39%, absences in
4%, and myoclonic jerks in 3%. In only 39% of case records was current seizure control documented. Seventy-four 
per cent and 41% of patients had surface electroencephalography and computerized tomographic brain scanning, 
respectively. In more than 80% of patients the presence or absence of birth injury, febrile convulsions in childhood, 
and a family history of epilepsy were not mentioned. Seventy-six per cent of patients were receiving anticonvulsant 
monotherapy. The most commonly prescribed rugs were carbamazepine (43%), phenytoin (34%), sodium 
valproate (22%) and phenobarbitone (15%). Eighty-four per cent had attended a hospital clinic with their epilepsy, 
and 19% had been admitted to hospital with seizures or complications. A standard record form for the assessment 
and follow-up of epileptic patients in general practice would help in providing optimal management and in 
facilitating the setting up of a shared-care programme. 
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INTRODUCTION 
Epilepsy is the second most common neurological 
disorder affecting an estimated 50 million people 
world-wide t. The incidence ranges from 50-122 
per 100000 individuals< It has a prevalence of 
5-10 per 1000, with a life-time prevalence of 
around 5%. Over 300,000 people in the UK have 
active epilepsy and more than 1 million will have 
a history of one or more seizures at some time in 
their life. A recent report suggests that epilepsy in 
the UK costs in the region of £1930 million per 
annum 3. 
Epilepsy brings the patient into contact with a 
number of medical and other agencies. However, 
despite this, there seem to be deficiencies in the 
overall level of care 4. This may be due to the 
variable quality of these services, their fragmen- 
tary nature and their poor organization s. In 
addition, epilepsy is a condition that carries a 
unique burden for the patient and his or her 
family. For many there is the effect, imagined and 
actual, of stigma resulting in considerable physi- 
cal, psychological nd social problems. 
There have been a number of audits of epilepsy 
in general practice, usually of small numbers of 
patients 5-t3. These studies, mainly of single 
practices, found that treatment was generally 
poor. There were deficiencies in care, particularly 
in the area of patient assessment and investiga- 
tion. Seizure control was inadequate. There was 
inappropriate prescription of anticonvulsant 
drugs. Drug concentrations were hardly ever 
measured. Chronic side effects were rarely 
recorded. Family doctors are the gatekeepers to 
secondary health care, and can only provide a 
high standard within a structure offering good 
specialist services. The West of Scotland Epilepsy 
Research Group (WOSERG) has carried out an 
audit of patients with treated epilepsy in 25 
general practices in Glasgow with a view to 
developing and setting up a shared-care 
programme. 
METHODS 
The protocol was designed by WOSERG, which 
included a number of general practitioners. The 
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prototype was discussed at the General Practice 
Subcommittee of the Greater Glasgow Area 
Medical Committee who made suggestions for 
improvement. A letter of introduction was then 
sent to all general practitioners working in 
Glasgow. This outlined the aims of the study and 
invited them to allow perusal of their patients' 
records. The protocol had the approval of the 
West of Scotland General Practice Ethical Com- 
mittee. A number of general practitioners agreed 
to take part. Practices were chosen to provide 
representation f the entire Glasgow population. 
From March 1993 to February 1994 the audit 
was carried out by a research nurse. All the 
patient records from 25 practices were examined. 
Demographic and clinical details were obtained 
from computerized records of repeat prescrip- 
tions for antiepileptic drugs. Patients taking these 
drugs for other indications were excluded by 
reviewing their notes. Of the 25 practices 
examined, 21 used the computer system GPASS 
and the remaining 4 had VAMP. 
Data were collected on a specially designed 
record form. The following information was 
Table 1: Practice sizes with the corresponding numbers of 
patients with epilepsy 
Practice Practice No. of Prevalence 
No. Size patients 
with 
epilepsy 
001 4058 36 0.89 
002* 4500 25 0.58 
003* 4000 34 0.85 
004 6934 44 0.63 
005 7420 66 0.89 
006 7150 55 0.77 
007 2447 17 0.69 
008 5535 38 0.69 
009 6571 52 0.79 
010" 8000 50 0.63 
011 3467 17 0.49 
012 1758 13 0.74 
013" 3800 19 0.50 
014" 4200 19 0.45 
015 5650 37 0.65 
016 3112 19 0.61 
017 6078 34 0.56 
018 3910 54 1.38 
019" 5000 50 1.00 
020 5947 57 0.96 
021 7789 87 1.12 
022 4697 26 0.55 
023 7286 53 0.73 
024 10911 66 0.60 
025 15389 83 0.54 
Total 145609 1052 0.72 
* Estimated size of practices on more than one site. 
obtained for each patient when available: (1) 
name, age and gender, (2) appropriateness of 
diagnosis, (3) specialist investigations, (4) class- 
ification of seizures, (5) duration of epilepsy, (6) 
history of birth injury, family history of epilepsy, 
febrile convulsions and any other potential 
aetiological factors, (7) current seizure control, 
(8) antiepileptic drug treatment, (9) attendances 
at hospital clinics, (10) referrals to Accident and 
Emergency Departments and hospital 
admissions. All data were later transcribed into a 
database created in Paradox for Windows. 
RESULTS 
Demography 
The audit included a total population of 145 609 
patients, 1052 (0.72%) of whom had treated 
epilepsy. The range of prevalences in individual 
practices is shown in Table 1. Five hundred and 
sixty-four (54%) patients were male and 488 
(46%) were female. The age range in decades is 
illustrated in Fig. 1. There were 53 (5%) children, 
while 203 (19%) patients were over 65 years of 
age. At the time of analysis, 322 were married, 82 
were divorced or separated, 277 were single and 
66 were widowed or widowered. The marital 
status of the remaining 252 (24%) patients was 
not entered in the notes. 
Employment details were available for 540 
patients. One hundred and eighteen had jobs, 203 
were retired and 219 were unemployed. The 
study also included 135 (13%) patients in whom 
the general practitioner had mentioned in the 
notes some degree of learning disability. The 
work status of the remaining 324 patients 
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Fig. 1: Number of patients with treated epilepsy by age. 
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(excluding the 53 children) could not be ascer- 
tained from the notes. 
Diagnosis 
Three hundred and ten (29%) patients had been 
diagnosed as having epilepsy (Fig. 2) by a 
neurologist, 256 (24%) by a general physician, 
110 (10%) by a paediatrician, 45 (4%) by a 
general practitioner, 38 (4%) by a neurosurgeon 
and 11 (1%) by a clinical pharmacologist with a 
specialist interest in epilepsy. A paediatric neuro- 
logist or a psychiatrist made the diagnosis in 7 
(0.7%) patients, and 6 (0.6%) were diagnosed by 
a geriatrician. In the remaining 250 (24%) 
patients, no record was available of who had 
made the diagnosis of epilepsy. 
Three hundred and two (29%) patients were 
diagnosed on clinical history alone. Two hundred 
and three (20%) had had an EEG performed as 
an aid to diagnosis. In 117 (11%) patients, one or 
more seizures had been witnessed. Twenty-six 
patients (2%) were started on an antiepileptic 
drug on the basis of a single seizure. Criteria for 
the diagnosis of epilepsy could not be found in the 
notes of 351 (33%) patients. Duration of anti- 
epileptic drug therapy is shown in Fig. 3. 
Seizures 
Five hundred and thirty-one patients (50%) had 
tonic-clonic seizures only. Partial seizures oc- 
curred in 353 (33%) patients, 179 (17%) of whom 
also had secondarily generalized tonic-clonic 
seizures. Less common seizure types were gene- 
ralized absences (n =49; 4%) and myoclonic 
jerks (n = 34: 3%). Seventeen (2%) patients had 
akinetic seizures, and 14 (1%) were thought to 
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Fig. 3: Duration of antiepileptic drug treatment. 
have pseudo-seizures, One hundred and thirty- 
seven patients were recorded as having more than 
one seizure type. In 121 (11%) patients it was not 
possible to deduce from the notes from what type 
of seizures the patient suffered. In only 414 (39%) 
patients was current seizure control documented 
in the case notes (Fig. 4). Of these, 302 patients 
(73%) were seizure-free. Another 33 reported 
more than five seizures per month. We were 
unable to obtain seizure frequency data for 61% 
of the patients. 
Predisposing factors 
In 627 (60%) patients a possible predisposing 
factor for the seizure disorder was identified. A 
major contributing factor was head trauma 
(n = 185). Alcohol abuse was considered to be 
relevant in 151 patients and 86 had suffered a 
cerebrovascular accident. Forty-two had had 
encephalitis or meningitis, 26 a neoplasm, 25 a 
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Fig. 2: Who made the diagnosis of epilepsy? 
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congenital malformation, 23cerebral atrophy and 
22 a perinatal problem. Eleven patients had 
seizures secondary to drug abuse. Another 55 
patients had a variety of other possible contribut- 
ing factors. 
Evidence of birth injury, febrile convulsions 
and a family history of epilepsy proved difficult o 
obtain. In 912 (87%) patients, no details of the 
birth were documented. In the remainder, 56 out 
of 140 had suffered birth injury. The figures for 
febrile convulsions showed a similar pattern with 
no available information i 925 (88%) patients. In 
the rest, 80 had not had febrile episodes, while 47 
patients had. We were unable to obtain a family 
history of epilepsy in 758 (72%) patients. In 114 
of the remaining 274 patients a family history of 
epilepsy was elicited. 
Investigations 
A total of 1466 surface electroencephalographic 
(EEG) examinations were carried out. Seven 
hundred and eighty-three patients (74%) had an 
EEG at some point in their history. Two hundred 
and fourteen of these had had two EEGs, 89 
three, 43 four and 18 five. Sixteen patients had six 
or more EEGs. In 269 (26%) patients with 
treated epilepsy, there was no evidence to suggest 
that an EEG had ever been performed. 
A total of 614 computerized tomographic (CT) 
brain scans had been carried out. Four hundred 
and thirty-four (41%) patients had had a CT scan 
performed. Three hundred and fifteen had one 
scan, 82 underwent a second, 25 a third, with 12 
having four or more. One hundred and fifty-three 
patients had isotope scans, and 9 were noted to 
have had magnetic resonance imaging of the 
brain. 
Table 2: Prescribed antiepileptic drugs 
Drug Patients 
Carbamazepine 453 (43%) 
Phenytoin 358 (34%) 
Sodium valproate 227 (22%) 
Phenobarbitone 160 (15%) 
Primidone 49 (5%) 
Lamotrigine 24 (2%) 
Vigabatrin 24 (2%) 
Clobazam 15 ( 1% ) 
Clonazepam 11 ( 1% ) 
Gabopentin 6 (I %) 
Ethosuximide 5 (0%) 
Potassium bromide 1 (0%) 
Remacemide 1 (0%) 
Tiagabine 1 (0%) 
Treatment 
Eight hundred and three (76%) patients were on 
anticonvulsant monotherapy and the remaining 
249 (24%) took more than one drug [211 (20%) 
two drugs, 33 (3%) three drugs, 2 four drugs]. 
The most commonly prescribed rugs (Table 2) 
were carbamazepine (43%), phenytoin (34%), 
sodium valproate (22%) and phenobarbitone 
(15%). Monitoring of drug serum levels was 
recorded in the notes of only 353 (34%) of 
patients. 
Hospital attendance 
Eight hundred and ninety-eight (85%) of the 
patients had attended a clinic for their epilepsy at 
some point in their history. When the diagnosis 
was made, 717 (68%) patients were investigated 
at an out-patient clinic (48% neurology, 26% 
general medicine, 16% paediatric, 5% epilepsy, 
4% neurosurgery, 1% psychiatry). The number of 
patients currently being seen at a hospital clinic 
was 296 (26%). This included neurology 134, 
epilepsy 59, general medicine 35, paediatric 32 
and psychiatry 14. Overall, 172 (16%) patients 
had attended an Accident and Emergency 
Department due to a seizure. One hundred and 
eleven (11%) had been kept overnight in 
hospital. A total of 202 (19%) patients had been 
admitted to hospital at some time with seizures or 
complications. 
DISCUSSION 
The mean prevalence figure for treated epilepsy 
in the 25 practices scrutinized was 0.72%, which is 
a little higher than previously reported 7"8. The 
range was 0.49-1.38%. The reasons for these 
differences were not obviously apparent. Today 
the elderly are becoming an increasing large part 
of society. The 'over sixty-fives' made up 19% of 
the patients urveyed in this audit, while only 5% 
were children. A similar observation in a Kent 
practice has been made recently by Cockerell and 
his colleagues 15. 
McKee 16, while examining admissions to ca- 
sualty at the Western Infirmary with a first 
seizure, found that 30% had alcohol as a possible 
predisposing factor. This may explain the male 
predominance in thie study, the high proportion 
of patients with head injury, and the substantial 
number with generalized tonic-clonic seizures. 
Most of the remaining patients had partial 
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seizures. Those with myoclonic epilepsy seemed 
under-represented ]7. The use of EEG and CT 
scans are important ools in classifying seizure 
type and identifying underlying pathology. Over a 
quarter of the patients had not had one of these 
investigations performed. Nearly 20% of the 
patients had been admitted to hospital due to 
their epilepsy. This provides a substantial con- 
tribution to the cost of epilepsy to the NHS 3. 
The move towards monotherapy, proposed 
initially by Shorvon and Reynolds in 197918, is 
gaining momentum. However, this goal is still 
unobtainable in the 25% of patients with refrac- 
tory epilepsy TM. We were pleased to note that 
more than 70% of patients were established on 
just on antiepileptic drug. Only 35 patients were 
receiving more than two agents. It is, perhaps, not 
surprising that 20% were still taking barbiturate 
drugs. Although current seizure control was not 
documented in more than 60% of patients, it is 
likely that anticonvulsant herapy could be 
withdrawn successfully in a substantial number of 
the 994 patients receiving treatment for more 
than 5 years. 
In this audit, we examined the case notes of 
more than 1000 patients with treated epilepsy. 
Overall, information was difficult to obtain since 
much of the necessary data were missing (Table 
3), including seizure classification, aetiological 
factors contributing towards the development of 
epilepsy (particularly birth trauma and family 
history of epilepsy), and the number of seizures 
that the patient currently suffered. Accurate 
classification of seizure type, in particular, is 
important in assisting the appropriate choice of 
antiepileptic drugs 2°. 
CONCLUSION 
Although it would be difficult to obtain unani- 
mous agreement on how epilepsy should be 
Table 3: Data missing from case notes 
Question Patients 
Who made diagnosis? 250 (24%) 
Criteria for diagnosis? 351 (33%) 
Seizure classification? 121 (11%) 
Seizure control? 638 (61%) 
Predisposing factors? 425 (40%) 
Family history? 756 (72%) 
Birth trauma? 912 (87%) 
Febrile convulsions? 925 (88%) 
Electroencephalogram? 269 (26%) 
Tomographic scan? 618 (59%) 
Clinic attendance? 154 (15%) 
managed, a consensus i emerging 5. As with any 
chronic condition certain principles are accepted: 
rapid initial assessment, suitable investigation, 
safe diagnosis, appropriate treatment, regular 
follow-up, periodic review and effective 
communication with the patient and his or her 
family. The general practitioner is required to 
co-ordinate this exercise. A standard protocol for 
documenting the initial assessment and long-term 
follow-up of patients with treated epilepsy would 
help in providing optimal investigation and 
management for this vulnerable patient 
population. This will set out to guide clinical 
management and decision-making within a locally 
agreed framework of shared-care 21. Such a system 
is being devised for Glasgow. 
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